MATTHEW MCGRATH: Open Payments
NPI 1841951001 · COOPERSTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$995 in 56 payments from 13 companies in 2025. Trend: 2023 $17 · 2024 $1,029 · 2025 $995
Food & beverage: $929Education: $66
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $291 |
| Arcutis Biotherapeutics, Inc. | 19 | $182 |
| ABBVIE INC. | 9 | $147 |
| GENZYME CORPORATION | 2 | $62 |
| Organon LLC | 3 | $54 |
| UCB, Inc. | 2 | $44 |
| LEO Pharma Inc. | 1 | $43 |
| PFIZER INC. | 2 | $41 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $29 |
| Incyte Corporation | 1 | $27 |
Products named: TREMFYA, Zoryve, SKYRIZI, DUPIXENT, VTAMA, Bimzelx, ADBRY, CIBINQO.
Industry payments across NY — which companies pay providers there.
